The National Institutes of Health and the Best Pharmaceuticals for Children Act.

@article{Zajicek2009TheNI,
  title={The National Institutes of Health and the Best Pharmaceuticals for Children Act.},
  author={Anne Zajicek},
  journal={Paediatric drugs},
  year={2009},
  volume={11 1},
  pages={45-7}
}
The majority of drugs used to treat children are not labeled for use in children. The Best Pharmaceuticals for Children Act of 2002, re-authorized as the US FDA Amendments Act of 2007, directs the National Institutes of Health (NIH) to sponsor pediatric clinical trials of drugs lacking patent protection, if the FDA request for studies has been declined. The NIH is currently sponsoring 17 clinical studies. Challenges encountered include a paucity of investigators who are trained in pediatric… CONTINUE READING

From This Paper

Topics from this paper.
14 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Similar Papers

Loading similar papers…